Tuberculosis-HIV co-infection: Policy and epidemiology in 25 countries in the WHO European region

HIV Medicine

Volumn 9, Issue 6, 2008, Pages 406-414

  Lazarus, J V ^a,b   Olsen, M ^c   Ditiu, L ^a   Matic, S ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Central Asia; Europe; HIV; TB HIV co infection; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; ISONIAZID;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CONTROLLED STUDY; EUROPE; FEMALE; HEALTH CARE NEED; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; SEX RATIO; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DISEASE PROGRESSION; EUROPE; FEMALE; HEALTH POLICY; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; RISK FACTORS; TUBERCULOSIS;

EID: 47649130101     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00567.x     Document Type: Article

References (29)

1. Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Int Med 2003; 163: 1009-1021.
2. Reid A, Scano F, Getahun H et al. Towards universal access to HIV prevention, treatment, care, and support: The role of tuberculosis/HIV collaboration. Lancet Infect Dis 2006; 6: 483-495.
3. World Health Organization. Strategic Framework to Decrease the Burden of TB/HIV. Geneva: World Health Organization, 2002.
4. Veen J, Godinho J. HIV and TB: A critical coinfection, In: Matic S, Lazarus JV, Donoghoe MC. eds. HIV/AIDS in Europe: Moving from Death Sentence to Chronic Disease Management. Copenhagen: World Health Organization Regional Office for Europe, 2006: 155-170.
5. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva: World Health Organization, 2007.
6. UNAIDS. Report on the Global AIDS Epidemic: A UNAIDS 10th Anniversary Special Edition. Geneva: Joint United Nations programme on HIV/AIDS (UNAIDS), 2006.
7. van der Werf MJ, Borgdorff MW. Targets for tuberculosis control: How confident can we be about the data? Bulletin of the World Health Organization 2007; 85: 377-386.
8. Stop TB Partnership. The Global Plan to Stop TB 2006-2015: Actions for Life: Towards a World Free of Tuberculosis. Geneva: World Health Organization, 2006.
9. World Health Organization. Interim Policy on Collaborative TB/HIV Activities. Geneva: World Health Organization, 2004.
10. World Health Organization. The Stop TB Strategy: Building on and Enhancing DOTS to Meet the TB-related Millennium Development Goals. Geneva: World Health Organization, 2006.
11. European Centre for the Epidemiological Monitoring of AIDS (EuroHIV). HIV/AIDS Surveillance in Europe: End Year Report 2005. No. 73. Saint-Maurice: French Institute for Public Health Surveillance, 2006.
12. Computerized Information System for Infectious Diseases (CISID). Copenhagen: WHO Regional Office for EuroHe. Available at: http://data.euro.who.int/cisid
13. Møller L, Stöver H, Jürgens R, Gatherer A, Nikogosian H. Health in Prisons: A WHO Guide to the Essentials in Prison Health. Copenhagen: WHO Regional Office for Europe, 2007.
14. Anglaret X, Chêne G, Attia A et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d' Ivoire: A randomised trial. Cotrimo-CI Study Group. The Lancet 1999; 353: 1463-1468.
15. Wiktor SZ, Sassan-Morokro M, Grant AD et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease the morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: A randomised controlled trial. The Lancet 1999; 353: 1469-1475.
16. Zachariah R, Spielmann MP, Harries AD, Gomani P, Bakali E. Cotrimoxazole prophylaxis in HIV infected individuals after completing antituberculosis treatment in Thyolo, Malawi. Int J Tuberculosis Lung Dis 2002; 6: 1046-1050.
17. Bollerup AR, Donoghoe M, Lazarus JV, Nielsen S, Matic S. Access to highly active antiretroviral therapy (HAART) in the WHO European Region 2003-2005. Scand J Public Health 2008, in press.
18. Laserson KF, Wells CD. Reaching the targets for tuberculosis control: the impact of HIV. Bull World Health Org 2007; 85: 377-386.
19. Schwalbe N, Lazarus JV, Adeyi O. HIV/AIDS and tuberculosis control in post-Soviet countries, In: Coker R, Atun RA, McKee M. eds. Health Systems and Communicable Diseases: Challenges to Transitional Societies. Buckingham: Open University Press, 2008, in press.
20. Coker R, Atun RA, McKee M. Untangling Gordian knots: Improving tuberculosis control through the development of 'programme theories'. Int J Health Planning Manage 2004; 19: 217-226.
21. World Health Organization. Management of Tuberculosis and HIV Coinfection: Clinical Protocol for the WHO European Region. Copenhagen: World Health Organization Regional Office for Europe, 2007.
22. World Health Organization Status Paper on Prisons and Tuberculosis. Copenhagen: World Health Organization Regional Office for Europe, 2007.
23. World Health Organization. European Framework to Decrease the Burden of TB/HIV. Copenhagen: World Health Organization Regional Office for Europe, 2003.
24. Atun RA, Lebcir RM, McKee M, Habicht J, Coker RJ. Impact of joined-up HIV harm reduction and multidrug resistant tuberculosis control programmes in Estonia: System dynamics simulation model. Health Policy 2007; 81: 207-217.
25. Donoghoe MC. Injecting drug use, harm reduction and HIV/AIDS, In: Matic S, Lazarus JV, Donoghoe MC. eds. HIV/AIDS in Europe: Moving from Death Sentence to Chronic Disease Management. Copenhagen: World Health Organization Regional Office for Europe, 2006: 43-66.
26. Guerrero A, Cobo J, Fortun J et al. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet 1997; 350: 1738-1742.
27. Dye C, Williams BG, Espinal MA, Raviglione MC. Erasing the world's slow stain: Strategies to beat multidrug-resistant tuberculosis. Science 2002; 295: 2042-2046.
28. Espinal MA, Perez EN, Baez J et al. Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: A prospective study. Lancet 2000; 355: 275-280.
29. World Health Organization. The Tuberculosis Challenge in the European Region. Copenhagen: World Health Organization Regional Office for Europe, 2004.